BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lovastatin
,
rs4950928
,
SLC12A1
,
T cell receptor signaling pathway
,
Arthritis
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
lung lymphangioleiomyomatosis
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Lung diseases
Lung nodules from lymphangioleiomyomatosis patients
Rapamycin-insensitive up-regulation of MMP2 and other genes in TSC2- deficient LAM-like cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Fatal Hemoptysis Due to Endobronchial Aspergilloma in the Hyperinflated Native Lung after Single-Lun…
Lung transplantation for lymphangioleiomyomatosis].
Correlation between the native lung volume change and postoperative pulmonary function after single …
Disease monitoring using lung function trajectory in lymphangioleiomyomatosis: assessment in two nat…
Novel Pulmonary Cyst Characteristics Associated with the Diffusing Capacity of the Lung in Lymphangi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Doxycycline In Lymphangioleiomyomatosis (LAM)
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
Study of the Disease Process of Lymphangioleiomyomatosis
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ